It is essential to gain an in-depth understanding of the impact on the pathogenic mechanisms of Alzheimer's disease, as it may involve multiple factors such as amyloid proteins, tau proteins, and neuroinflammation. Treatment targeting tau alone may be insufficient to address the progression of chronic lesions. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.